TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33761995 — Predictive Biomarker (PRD): Hormone receptor
Study 33762234 — Surrogate Endpoint (SUR): Blood pressure
Study 33762322 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33762322 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 33762734 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33763241 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 33763241 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 33763653 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33763756 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33764808 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33764809 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33765041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33765041 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33765092 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 33765419 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33765691 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 33765926 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33765926 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33765926 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 33766105 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 33766994 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 33767059 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study 33767093 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33767162 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 33767162 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33767695 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 33767695 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 33768217 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD
Study 33769355 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 33769355 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 33769497 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 33769555 — Surrogate Endpoint (SUR): Blood pressure
Study 33769555 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33769953 — Surrogate Endpoint (SUR): Serum potassium
Study 33770018 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 33770291 — Predictive Biomarker (PRD): Microsatellite instability
Study 33770527 — Predictive Biomarker (PRD): ZFYVE9 mRNA
Genes: ZFYVE9; MADHIP; SARA; SMADIP
Study 33770527 — Predictive Biomarker (PRD): SGCA mRNA
Genes: SGCA; ADL; DAG2
Study 33770575 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33770575 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 33770575 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 33770575 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 33770575 — Predictive Biomarker (PRD): SH2B3 mRNA
Genes: SH2B3; LNK
Study 33771885 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 33773598 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33774438 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33774438 — Safety Biomarker (SAF): BDNF
Study 33774745 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 33774767 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33774767 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 33775123 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33775127 — Surrogate Endpoint (SUR): Blood pressure
Study 33775523 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33776798 — Surrogate Endpoint (SUR): Blood pressure
Study 33776910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33776910 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33776910 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33777758 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33778150 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33778934 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 33779567 — Surrogate Endpoint (SUR): Blood pressure
Study 33779569 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 33780662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33782211 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33782940 — Surrogate Endpoint (SUR): Blood pressure
Study 33782940 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33782940 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33783067 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33783067 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 33783145 — Surrogate Endpoint (SUR): Bone mineral density
Study 33783375 — Predictive Biomarker (PRD): PAPPA2 mRNA
Genes: PAPPA2; PLAC3
Study 33783498 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 33783586 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33783815 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33785324 — Predictive Biomarker (PRD): NOCT mRNA
Genes: NOCT; CCR4; CCRN4L; NOC
Study 33785590 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 33786329 — Safety Biomarker (SAF): Hyaluronic acid
Study 33786583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33786851 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33787530 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33787530 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33789265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33789701 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 33789701 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 33790041 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 33790870 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 33790901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33790901 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 33790901 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33790901 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33790901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33791217 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33791343 — Surrogate Endpoint (SUR): Blood pressure
Study 33792221 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 33792221 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study 33792222 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 33792627 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study 33792960 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 33792960 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 33793363 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 33793651 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33794206 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33794206 — Predictive Biomarker (PRD): Hormone receptor
Study 33794315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33794315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33794440 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33794440 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33794440 — Predictive Biomarker (PRD): Hormone receptor
Study 33794793 — Surrogate Endpoint (SUR): Blood pressure
Study 33794793 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33794832 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33795193 — Predictive Biomarker (PRD): Solute carrier family 29 member 1
Genes: SLC29A1; ENT1
Study 33795869 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study 33796147 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33796147 — Predictive Biomarker (PRD): Anti-acetylcholine receptor antibody
Study 33796237 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33796451 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33796452 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33796452 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33796490 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33799966 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33800872 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33802089 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33804500 — Predictive Biomarker (PRD): LRRFIP1 mRNA
Genes: LRRFIP1; GCF2; TRIP
Study 33805731 — Surrogate Endpoint (SUR): Pathological complete response
Study 33809538 — Predictive Biomarker (PRD): Hormone receptor
Study 33811727 — Predictive Biomarker (PRD): CHFR mRNA
Genes: CHFR; RNF196
Study 33811727 — Predictive Biomarker (PRD): Microsatellite instability
Study 33812668 — Surrogate Endpoint (SUR): Blood pressure
Study 33813637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33813727 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 33814284 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33817379 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 33818022 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33818022 — Predictive Biomarker (PRD): Hormone receptor
Study 33818037 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33818698 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 33820779 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33820779 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33820779 — Predictive Biomarker (PRD): Hormone receptor
Study 33820780 — Predictive Biomarker (PRD): LRRC15 mRNA
Genes: LRRC15; LIB
Study 33822526 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 33822828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33822828 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33822828 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 33822828 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 33822961 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33823811 — Surrogate Endpoint (SUR): Blood pressure
Study 33823929 — Predictive Biomarker (PRD): DDX11 mRNA
Genes: DDX11; CHL1; CHLR1; KRG2
Study 33823929 — Predictive Biomarker (PRD): KDM5C mRNA
Genes: KDM5C; DXS1272E; JARID1C; SMCX; XE169
Study 33823929 — Predictive Biomarker (PRD): FOXC2 mRNA
Genes: FOXC2; FKHL14; MFH1
Study 33823929 — Predictive Biomarker (PRD): CLIP4 mRNA
Genes: CLIP4; RSNL2
Study 33823929 — Predictive Biomarker (PRD): AQP1 mRNA
Genes: AQP1; CHIP28
Study 33823929 — Predictive Biomarker (PRD): BAIAP2L1 mRNA
Genes: BAIAP2L1; IRTKS
Study 33823929 — Predictive Biomarker (PRD): TMEM38B mRNA
Genes: TMEM38B; C9orf87
Study 33824079 — Surrogate Endpoint (SUR): Blood pressure
Study 33824433 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 33824476 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33825765 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 33825965 — Predictive Biomarker (PRD): CSAD mRNA
Genes: CSAD; CSD
Study 33826106 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33826112 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 33826362 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 33827116 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33827139 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 33829021 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 33829867 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33829867 — Safety Biomarker (SAF): BDNF
Study 33829991 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 33831732 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33831901 — Surrogate Endpoint (SUR): Blood pressure
Study 33832565 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33832946 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study 33833048 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 33835229 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33835229 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33836153 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33836262 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33836262 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33836889 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33837912 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33838339 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 33838463 — Predictive Biomarker (PRD): EHF mRNA
Genes: EHF; ESE3; ESE3B; ESEJ
Study 33839064 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33840050 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33840068 — Surrogate Endpoint (SUR): Blood pressure
Study 33840743 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33840743 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33842908 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33843247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33843247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33843785 — Predictive Biomarker (PRD): TJP1 mRNA
Genes: TJP1; ZO1
Study 33843785 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 33843785 — Predictive Biomarker (PRD): CLDN1 mRNA
Genes: CLDN1; CLD1; SEMP1; UNQ481/PRO944
Study 33843785 — Predictive Biomarker (PRD): CLDN12 mRNA
Genes: CLDN12
Study 33843785 — Predictive Biomarker (PRD): TFF1 mRNA
Genes: TFF1; BCEI; PS2
Study 33843785 — Predictive Biomarker (PRD): MYLK mRNA
Genes: MYLK; MLCK; MLCK1; MYLK1
Study 33843785 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 33843785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 33843785 — Predictive Biomarker (PRD): SLC9A1 mRNA
Genes: SLC9A1; APNH1; NHE1
Study 33844595 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 33845032 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 33845905 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33845905 — Predictive Biomarker (PRD): Hormone receptor
Study 33846845 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33847032 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33847257 — Predictive Biomarker (PRD): LSR mRNA
Genes: LSR; ILDR3; LISCH
Study 33847874 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 33849562 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 33849562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33852104 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33852146 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33852450 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 33854566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33855675 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study 33855751 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 33856003 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33856360 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 33856599 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 33856599 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 33857917 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33858326 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study 33858326 — Predictive Biomarker (PRD): COL2A1 mRNA
Genes: COL2A1
Study 33858486 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 33859620 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 33859620 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33859707 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 33860387 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33860387 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33860387 — Predictive Biomarker (PRD): Hormone receptor
Study 33860922 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33861210 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 33861303 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 33862302 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study 33863399 — Predictive Biomarker (PRD): PTGDS mRNA
Genes: PTGDS; PDS
Study 33863713 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33863774 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33863808 — Predictive Biomarker (PRD): Interleukin 4 receptor alpha
Genes: IL4R; IL4RA; 582J2.1
Study 33863913 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 33863913 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 33863913 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33863913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 33864948 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33865615 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 33865615 — Predictive Biomarker (PRD): NTRK
Study 33866938 — Predictive Biomarker (PRD): Microsatellite instability
Study 33868439 — Surrogate Endpoint (SUR): Blood pressure
Study 33869653 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33870151 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 33870151 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33870413 — Monitoring Biomarker (MOI): Cell-free DNA
Study 33871700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33871807 — Predictive Biomarker (PRD): CCR9 mRNA
Genes: CCR9; GPR28
Study 33875560 — Predictive Biomarker (PRD): SLC4A7 mRNA
Genes: SLC4A7; BT; NBC2; NBC2B; NBC3; NBCn1; SBC2; SLC4A6
Study 33875611 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33875611 — Surrogate Endpoint (SUR): Pathological complete response
Study 33875845 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 33875845 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 33876222 — Predictive Biomarker (PRD): ERFE mRNA
Genes: ERFE; C1QTNF15; CTRP15; FAM132B
Study 33876222 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33876469 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study 33877496 — Surrogate Endpoint (SUR): Bone mineral density
Study 33877856 — Predictive Biomarker (PRD): ROCK2 mRNA
Genes: ROCK2; KIAA0619
Study 33878020 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33878339 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 33879094 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33879094 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 33879189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33879189 — Monitoring Biomarker (MOI): Procalcitonin
Study 33879253 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 33879458 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33879515 — Predictive Biomarker (PRD): DNAJB1 mRNA
Genes: DNAJB1; DNAJ1; HDJ1; HSPF1
Study 33879515 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 33879601 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study 33879601 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33879601 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33879601 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33881209 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1